The First 5 Hires for a Platform Biotech: Who, When, and Why?
- sharonshieldsconsu
- Jul 30
- 5 min read
A practical hiring sequence to turn a cool idea into a real, fundable company.
Platform biotechs don’t usually fail because the science is bad on paper. They fail because they never turn that science into a repeatable, defensible engine that generates data, programs, and deals.
Your first five hires either make that engine… or they don’t.
Below is a simple, VC-friendly way to think about who to hire, when, and why they matter.
Platform Architect (Founding Scientific Lead)
Who
The person who owns the platform. They design and run the core workflow: assays, models, automation, and data quality. Often this is the scientific founder. If not, it should be a senior scientist/engineer capable of:
Designing the overall platform architecture
Making hard technical trade-offs
Setting the scientific bar for future hires
This mirrors the emphasis many investors and talent practitioners put on a clear technical “platform owner” as a foundational hire for biotechs [1][4][5].
When
Day 0. This is not a “nice to have”; this hire is the company.
If your founding team doesn’t include a clear Platform Architect, you don’t yet have a platform biotech – you have an idea.
Why
Turns vision into a concrete experimental and data plan
Prioritises the right proof points for investors and partners
Ensures early data is robust enough to stand up under scrutiny
The “Glue” Operator (Head of Operations / Chief of Staff)
Who
A Swiss‑army‑knife operator who owns everything that isn’t core science:
Lab setup and facilities
Vendors, CROs, and purchasing
Basic finance, HR/admin, and contracts
Project coordination and board/milestone prep
Titles vary: Head of Operations, Operations Manager, Chief of Staff. What matters is that they are organised, pragmatic, and comfortable in chaos. This “glue” operator is consistently highlighted as a make‑or‑break early hire for biotechs and tech startups alike [1][2][3][6].
When
Hire #2–3, as soon as your Platform Architect is spending more than ~30–40% of their time on operational tasks [2][6].
Why
Frees founders to focus on science and strategy
Gets Lab 1.0 up fast: space, equipment, safety, systems
Keeps experiments aligned with milestones, burn, and runway
Creates a single point of accountability for “everything else”
Without this person, founders drown in logistics, and scientific milestones quietly slip.
Biology ↔ Data / Platform Infrastructure Lead
Who
The person who turns experiments into a scalable platform, not a pile of one-off studies. Depending on your modality, this might be:
A computational biologist / bioinformatician
A data/ML engineer embedded in biology
A platform engineer for high-throughput or automated systems
They live at the interface of bench and data: pipelines, infrastructure, and feedback loops. For data‑driven and AI‑enabled platforms, this “bridge” role is one of the most important early differentiators [4][5].
When
Hire #3–4, once:
You have a repeatable experimental workflow
You’re generating non-trivial amounts of data
You can see “platform” value, but it’s still fragile and manual
Why
Prevents a “data swamp”: irreproducible experiments, fragmented storage, no metadata
Builds the feedback loop between experiments, analysis, and next designs
Makes your “platform” defensible by accumulating structured, reusable data and know-how
Underpins the story that you can run many programs more efficiently over time [4][5]
This is the person who makes your platform pitch real.
Early Regulatory / Quality Voice (Often Fractional)
Who
A regulatory or quality leader (often fractional/consultant at first) who has already taken something through a regulated path: preclinical to IND/CTA, diagnostic validation, or equivalent.
They won’t own full-time QA/RA from day one, but they will:
Pressure-test your development plan
Tell you what’s “good enough” vs. risky in early data and documentation
Help design studies that won’t need costly re‑runs later
Several biotech-focused hiring guides now argue this kind of early RA/QA voice is one of the “hidden” first 5 hires, even if part-time [1][2][3].
When
Therapeutics / diagnostics: involve them by hire #3–4, at least part-time [1][2]
Tools / infrastructure: bring them in as soon as you touch patients, clinical workflows, or sensitive health data [3]
Why
Ensures early experiments and documentation are usable later (no “we have to redo 18 months of work”)
Shapes a credible path from “interesting platform data” to an actual product
Surfaces regulatory and quality landmines before they appear in an IND/CTA or partner diligence
Reassures investors that you’re building with the end in mind, not improvising later
You can easily over-hire here (too senior, too early, full-time). But ignoring this voice entirely usually shows up later as expensive delays.
Business / Fundraising Partner
Who
A science-literate dealmaker who can own fundraising narrative, investor relations, and early BD while speaking fluently with your Platform Architect.
Typical backgrounds:
Former VC associate/principal with strong life sciences exposure
Ex-BD or strategy lead from biotech, pharma, or a tools company
Scientist-operator (e.g., PhD/MD + consulting/startup) who is unusually strong on story and stakeholder management
They don’t need to be a CFO. They do need to:
Understand the platform and its implications
Build a coherent financing and partnering strategy
Run structured investor and BD processes, not just “coffee chats”
The importance of a dedicated business/fundraising profile in the first wave of hires is a common theme across startup advice, especially where founders are deeply technical [1][2][3][6].
When
Typically hire #4–5, around or ahead of a major financing or partnering push.
Before or around Series A if the founder is weaker on narrative/BD
Later (post-Series A) if the founder is already strong here and can carry early rounds
Often starts fractional or project-based (e.g., seed → Series A), then becomes full-time as BD and financing complexity grow
Why
Translates platform and data into a crisp “why us, why now, why this market” story
Runs fundraising and BD processes so founders can keep building the company
Maintains a warm pipeline of investors and partners (you’re not always raising in panic mode)
Increases the quality of investors and partners, not just the quantity of conversations [2][3][6]
Done well, this hire turns your platform from an interesting deck into a fundable and partnerable business.
How a Talent Partner Can Help
If you’re a founder or VC:
I can help you map these 5 roles onto your specific platform and modality
Define profiles, scorecards, and realistic comp for each hire
Decide where to go full-time vs fractional, and in what order
Used well, this sequence keeps your company focused on the two things that matter most in the first 18 months: building a real platform, and staying funded long enough to prove it.
References
Miguel Soares Brás – “The first 5 hires in a biotech startup will make or break your company” (LinkedIn, 2024).
Christian Rados – “First 5 hires every biotech needs” (LinkedIn, 2024).
BEC Search – “Life Sciences Startup: Foundational Hires for Biotech and Pharma” (BEC Search blog).
Aspire Life Sciences Search – “Hiring for platform biotechs” (Life Science Lens series, LinkedIn).
Biotech United – “Hiring Smart: A Biotech Startup’s Guide to Building the Right Team From Day One” (Biotech United blog).
Due.com – “The First 5 Hires That Make or Break Your Startup” (Due.com, startup operations).
Comments